+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID07701967

Evaluating 100 mg Subcutaneous Depemokimab Alone for Japanese Adults with Chronic Rhinosinusitis and Nasal Polyps Who Have Not Responded to Standard Treatments

Led by GlaxoSmithKline · Updated on 2026-09-08

28

Participants Needed

10

Research Sites

50 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to assess the effectiveness and safety of depemokimab GSK3511294 used alone, without intranasal corticosteroids INCS, in Japanese adults with chronic rhinosinusitis with nasal polyps CRSwNP who have not responded well to standard treatments. The study focuses on participants with significant nasal polyp symptoms and evaluates changes in nasal polyp size and symptom relief over time. Participants will receive 100 mg of depemokimab as a monotherapy along with their existing standard care for CRSwNP excluding intranasal corticosteroids. This is a Phase IV, single-arm, open-label study where all participants receive the same treatment and are monitored throughout the study period of up to 52 weeks. During the study, participants will be regularly assessed for nasal polyp size using endoscopic scoring, symptom severity such as nasal obstruction, runny nose, and loss of smell using verbal response scales, and overall quality of life through the Sino-nasal Outcome Test SNOT-22. Imaging with CT scans will also be performed at the start and end of the study. The main outcome measured is the percentage of participants who achieve a significant reduction in nasal polyp size without needing surgery or other nasal treatments by Week 52.

CONDITIONS

Brief Title

Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Research Team

U

US GSK Clinical Trials Call Center

E

EU GSK Clinical Trials Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here